IDEXX Laboratories Inc (NASDAQ:IDXX) — Market Cap & Net Worth
Market Cap & Net Worth: IDEXX Laboratories Inc (IDXX)
IDEXX Laboratories Inc (NASDAQ:IDXX) has a market capitalization of $43.83 Billion ($43.83 Billion) as of August 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #616 globally and #298 in its home market, demonstrating a 3.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IDEXX Laboratories Inc's stock price $559.07 by its total outstanding shares 78882997 (78.88 Million). See reinvestment intensity of IDEXX Laboratories Inc to understand how much of operating cash flow is reinvested back into capital assets.
IDEXX Laboratories Inc Market Cap History: 2015 to 2026
IDEXX Laboratories Inc's market capitalization history from 2015 to 2026. Data shows growth from $5.75 Billion to $44.10 Billion (20.58% CAGR).
Index Memberships
IDEXX Laboratories Inc is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$61.17 Trillion | 0.07% | #228 of 503 |
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 1.78% | #8 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.11% | #87 of 3165 |
|
Nasdaq 100
NDX
|
$33.68 Trillion | 0.13% | #72 of 101 |
Weight: IDEXX Laboratories Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
IDEXX Laboratories Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IDEXX Laboratories Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
12.40x
IDEXX Laboratories Inc's market cap is 12.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
50.37x
IDEXX Laboratories Inc's market cap is 50.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $9.25 Billion | $1.78 Billion | $222.04 Million | 5.21x | 41.66x |
| 2017 | $12.34 Billion | $1.97 Billion | $263.14 Million | 6.26x | 46.88x |
| 2018 | $14.67 Billion | $2.21 Billion | $377.03 Million | 6.63x | 38.92x |
| 2019 | $20.60 Billion | $2.41 Billion | $427.72 Million | 8.56x | 48.16x |
| 2020 | $39.43 Billion | $2.71 Billion | $581.78 Million | 14.57x | 67.78x |
| 2021 | $51.94 Billion | $3.22 Billion | $744.85 Million | 16.15x | 69.73x |
| 2022 | $32.18 Billion | $3.37 Billion | $679.09 Million | 9.56x | 47.39x |
| 2023 | $43.78 Billion | $3.66 Billion | $845.04 Million | 11.96x | 51.81x |
| 2024 | $32.61 Billion | $3.90 Billion | $887.87 Million | 8.37x | 36.73x |
| 2025 | $53.37 Billion | $4.30 Billion | $1.06 Billion | 12.40x | 50.37x |
Competitor Companies of IDXX by Market Capitalization
Companies near IDEXX Laboratories Inc in the global market cap rankings as of August 1, 2026.
Key companies related to IDEXX Laboratories Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.77 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $137.72 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #648 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
- Agilent Technologies Inc (NYSE:A): Ranked #689 globally with a market cap of $39.17 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.77 Billion | $574.30 |
| #169 | Danaher Corporation | NYSE:DHR | $137.72 Billion | $194.98 |
| #648 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
| #689 | Agilent Technologies Inc | NYSE:A | $39.17 Billion | $138.37 |
IDEXX Laboratories Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, IDEXX Laboratories Inc's market cap moved from $5.75 Billion to $ 44.10 Billion, with a yearly change of 20.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $44.10 Billion | -17.36% |
| 2025 | $53.37 Billion | +63.63% |
| 2024 | $32.61 Billion | -25.51% |
| 2023 | $43.78 Billion | +36.06% |
| 2022 | $32.18 Billion | -38.04% |
| 2021 | $51.94 Billion | +31.73% |
| 2020 | $39.43 Billion | +91.43% |
| 2019 | $20.60 Billion | +40.38% |
| 2018 | $14.67 Billion | +18.95% |
| 2017 | $12.34 Billion | +33.35% |
| 2016 | $9.25 Billion | +60.82% |
| 2015 | $5.75 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of IDEXX Laboratories Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $43.83 Billion USD |
| MoneyControl | $43.83 Billion USD |
| MarketWatch | $43.83 Billion USD |
| marketcap.company | $43.83 Billion USD |
| Reuters | $43.83 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urin… Read more